Author

Polyxeni Kevrekidou

SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?
SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?

SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?
SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?

Polyxeni Kevrekidou  et al.

CLINICAL SIGNIFICANCE OF INCIDENTAL COLONIC FOCAL 18F-FDG PET/CT UPTAKE. THE EXPERIENCE OF A CANCER CENTER
CLINICAL SIGNIFICANCE OF INCIDENTAL COLONIC FOCAL 18F-FDG PET/CT UPTAKE. THE EXPERIENCE OF A CANCER CENTER

SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?
SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?

Polyxeni Kevrekidou

FATIGUE IS NOT RELATED TO SARCOPENIA IN CROHN'S DISEASE PATIENTS IN DEEP REMISSION
FATIGUE IS NOT RELATED TO SARCOPENIA IN CROHN'S DISEASE PATIENTS IN DEEP REMISSION

Polyxeni Kevrekidou  et al.

CLINICAL SIGNIFICANCE OF INCIDENTAL COLONIC FOCAL 18F-FDG PET/CT UPTAKE. THE EXPERIENCE OF A CANCER CENTER
CLINICAL SIGNIFICANCE OF INCIDENTAL COLONIC FOCAL 18F-FDG PET/CT UPTAKE. THE EXPERIENCE OF A CANCER CENTER

Polyxeni Kevrekidou  et al.

“REAL WORLD” PRELIMINARY DATA ON THE EFFICACY AND SAFETY OF 16-WEEK INDUCTION THERAPY WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS
“REAL WORLD” PRELIMINARY DATA ON THE EFFICACY AND SAFETY OF 16-WEEK INDUCTION THERAPY WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS

Polyxeni Kevrekidou  et al.

THE NATURAL HISTORY OF COVID-19 IN PATIENTS WITH IBD: A NATIONWIDE STUDY BY THE HELLENIC SOCIETY FOR THE STUDY OF IBD
THE NATURAL HISTORY OF COVID-19 IN PATIENTS WITH IBD: A NATIONWIDE STUDY BY THE HELLENIC SOCIETY FOR THE STUDY OF IBD

Polyxeni Kevrekidou  et al.

Item 1 - 8 / 8
1